| Literature DB >> 17471239 |
N Azoitei1, A Brey, T Busch, S Fulda, G Adler, T Seufferlein.
Abstract
Thirty-eight-negative kinase 1 (TNK1) is a member of the ACK-family of nonreceptor tyrosine kinases and was originally cloned from CD34+/Lin-/CD38-hematopoietic stem/progenitor cells. The signaling pathways induced by TNK1 are largely unknown. Here, we report that expression and consequent activation of TNK1 enables tumor necrosis factor alpha (TNFalpha)-induced apoptosis by selectively inhibiting TNFalpha-induced activation of nuclear factor-kappaB (NF-kappaB). TNK1 has no effect on NF-kappaB DNA binding or the composition of the NF-kappaB complex; however, the kinase markedly prevents TNFalpha-induced NF-kappaB transactivation. TNK1 therefore acts as a novel molecular switch that can determine the properties of TNFalpha signaling and therefore cell death.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17471239 DOI: 10.1038/sj.onc.1210476
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867